2024 Global Drug of Abuse Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 12 Assays, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities for Suppliers
This new 318-page report from VPGMarketResearch contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report is available by section, and can be customized to specific information needs and budget.The report provides test volume and sales forecasts by country and market segment for the following assays:
AmphetaminesAntidepressantsBarbituratesBenzodiazepinesCannabinoids/MarijuanaCocaineLSDMethadoneMethaqualoneOpiatesPhencyclidine (PCP)Propoxphene
During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This unique study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.
Contains 318 pages and 68 tables
AmphetaminesAntidepressantsBarbituratesBenzodiazepinesCannabinoids/MarijuanaCocaineLSDMethadoneMethaqualoneOpiatesPhencyclidine (PCP)Propoxphene
During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This unique study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.
Contains 318 pages and 68 tables
Introduction
Worldwide Market and Technology Overview
A. Major Drugs of Abuse
1. OVERVIEW
2. TEST METHODOLOGIES
3. AMPHETAMINES
4. BARBITURATES
5. BENZODIAZEPINES
6. CANNABINOIDS/MARIJUANA
7. COCAINE
8. LYSERGIC ACID DIETHYLAMIDE (LSD)
9. METHADONE
10. METHAQUALONE
11. OPIATES
12. PHENCYCLIDINE
13. TRICYCLIC ANTIDEPRESSANTS
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alfa Wassermann, AMS,
Awareness Technologies, Beckman Coulter, Binding Site,
bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics,
Polymedco, Randox, Roche, Siemens, Tosoh, Vital
Diagnostics and other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
Table of Contents (Continued)
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. IT AND AUTOMATION
5. DRY CHEMISTRY
6. BIOSENSORS
France: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Japan: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Spain: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
UK: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
USA: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
Worldwide Market and Technology Overview
A. Major Drugs of Abuse
1. OVERVIEW
2. TEST METHODOLOGIES
3. AMPHETAMINES
4. BARBITURATES
5. BENZODIAZEPINES
6. CANNABINOIDS/MARIJUANA
7. COCAINE
8. LYSERGIC ACID DIETHYLAMIDE (LSD)
9. METHADONE
10. METHAQUALONE
11. OPIATES
12. PHENCYCLIDINE
13. TRICYCLIC ANTIDEPRESSANTS
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC analyzers
manufactured by Abaxis, Abbott, Alfa Wassermann, AMS,
Awareness Technologies, Beckman Coulter, Binding Site,
bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba,
Medica, Nova Biomedical, Ortho-Clinical Diagnostics,
Polymedco, Randox, Roche, Siemens, Tosoh, Vital
Diagnostics and other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential Applications
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
° Overview
° ELISA
° EMIT
° Electrochemical
Table of Contents (Continued)
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. IT AND AUTOMATION
5. DRY CHEMISTRY
6. BIOSENSORS
France: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Japan: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Spain: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
UK: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
USA: Test Volume and Sales Forecasts by Assay and Market Segment,
And Major Supplier Market Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
